To study the possible physiological role of atrial natriuretic peptide (ANP) in the regulation of intraocular pressure (IOP) the effects of an increase of endogenous ANP within the physiological range induced by the neutral endopeptidase 24.11 (NEP) inhibitor candoxatril were examined. In a single masked placebo controlled trial, seven patients were studied with normal IOP (six male, one female; average age 50 (range 37-62 years). Intraocular pressure in each eye was measured after 2 weeks of placebo, after 4 weeks of candoxatril 200 mg twice daily, and during the first 3 days of placebo washout. With 4 weeks of candoxatril, endogenous plasma ANP levels increased from 4-2 (SEM 1.5) to 6*0 (1.5) pmol/ I (p<004) and there was a significant decrease in mean arterial pressure from 119 (4) A role for atrial natriuretic peptide (ANP) in the regulation of intravascular fluid volume and blood pressure is now well established.
A role for atrial natriuretic peptide (ANP) in the regulation of intravascular fluid volume and blood pressure is now well established.
I There is also preliminary evidence for pharmacological effects of ANP on the regulation of aqueous humour production and of intraocular pressure (IOP). Atrial natriuretic peptide has been identified in the anterior uvea in the rat, 3 and specific receptors for ANP have been demonstrated in the pigmented epithelium of the ciliary processes in the rabbit. 4 Intravenous or intravitreal injection of pharmacological doses of ANP cause a reduction in aqueous humour production and lower IOP in the rabbit.5-9 In primates, administration of ANP intravenously, or by injection into the anterior chamber of the eye, increases uveoscleral outflow.'0 Furthermore, acute intravenous injection of high dose ANP in patients with pathologically raised IOP reduced the intraocular pressure by around 15%." However, it is unclear whether ANP plays a physiological role in the regulation of IOP. Neutral (Fig  1) . The fall in IOP with NEP inhibition was greater, the higher the initial IOP (Fig 2) . During the placebo controlled washout period, IOP returned towards baseline values in four of the five subjects in which these measurements were obtained (right eye 15 (1) up to 17 (1) mm Hg, left eye 13 (1) up to 15 (1) mm Hg).
EFFECTS OF NEP INHIBITION ON ANP LEVELS AND BLOOD PRESSURE
With chronic NEP inhibition there was a rise in plasma ANP from 4-2 (SEM 1-5) to 6-0 (1) (2) (3) (4) (5) pmol/l (p<004) and a significant decrease in mean arterial pressure (119 (4) to 110 (3) mm Hg, p<002; mean decrease in pulse pressure: 4 (4) mm Hg). The fall in IOP after 4 weeks of NEP inhibition was positively correlated with the increase in endogenous plasma ANP concentration (Fig 3) . However, there was no correlation between the decrease in IOP with candoxatril and the change in systemic blood pressure (data not shown).
Discussion
The major finding ofour study was that elevation of endogenous ANP within the physiological range by NEP inhibition is associated with a significant reduction in TOP in the normal eye. The observation that the decrease in IOP in the present study was positively correlated with the increase of endogenous ANP levels provides additional evidence that plasma ANP may have an important role in the normal regulation of IOP.
Inhibition of NEP 24.11 affects the meta- 
